PUBLISHER: The Business Research Company | PRODUCT CODE: 1681970
PUBLISHER: The Business Research Company | PRODUCT CODE: 1681970
Blockchain in genomics refers to the application of blockchain technology in the genomics field, integrating the decentralized and secure characteristics of blockchain with the storage, sharing, and analysis of genomic data. This application creates a blockchain-based platform that allows individuals to securely store and share their genomic data.
The main services within the blockchain in genomics market include utility tokens and blockchain platforms. In the context of cryptocurrency and blockchain, utility tokens are tokens with a specific use and offer utility within a particular ecosystem. The business models involved in this market encompass business-to-business (B2B), business-to-consumer (B2C), and consumer-to-business (C2B) models. These models find applications such as data sharing and monetization, data storage and security, and automated health insurance. The end users of blockchain in genomics include pharmaceutical and biotechnology companies, hospitals and healthcare providers, research institutes, data owners, and other stakeholders in the genomics ecosystem.
The blockchain in genomics market research report is one of a series of new reports from The Business Research Company that provides blockchain in genomics market statistics, including biochemical industry global market size, regional shares, competitors with blockchain in genomics market share, detailed blockchain in genomics market segments, market trends, and opportunities, and any further data you may need to thrive in blockchain in genomics industry. This blockchain in genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The blockchain in genomics market size has grown exponentially in recent years. It will grow from $0.84 billion in 2024 to $1.01 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to rising developments in genomics, rising adoption of digital tools, digitization of healthcare services by patients, increasing interest in blockchain technologies and their capabilities, rising awareness about the potential benefits of blockchain in genomics.
The blockchain in genomics market size is expected to see rapid growth in the next few years. It will grow to $2.01 billion in 2029 at a compound annual growth rate (CAGR) of 18.7%. The growth in the forecast period can be attributed to increasing demand for secure and efficient storage and retrieval of genomic data, growing adoption of blockchain-based solutions for genomic data sharing, rising investment in research and development activities in genomics, increasing government investments in healthcare research and development. Major trends in the forecast period include advancements in blockchain-based technologies for genomic data storage and retrieval, technological advancements, innovative development, increased investment and funding, blockchain in bioinformatics.
The increasing adoption of digital tools is expected to drive the growth of the blockchain in genomics market. Digital adoption refers to the integration of new digital technologies and systems to improve processes and achieve goals. The global COVID-19 pandemic acted as a major catalyst for this shift, as lockdowns and social distancing measures pushed individuals and businesses to rely on digital tools for communication, education, shopping, and entertainment. In genomics, digital tools like software, hardware, and online platforms are used in blockchain applications to enhance encryption and security, ensuring the confidentiality and protection of genomic data. For example, in May 2024, Eurostat, a Luxembourg-based government agency, reported that in 2023, 8.5% of individuals in the EU aged 16 to 74 participated in online consultations using the internet. This growing demand for digital health solutions is fueling the expansion of blockchain in genomics.
The burgeoning demand for personalized medicine is poised to fuel the expansion of the blockchain in genomics market. Personalized medicine, characterized by tailoring healthcare decisions and treatments to individual patient characteristics, is gaining prominence due to the increasing burden of chronic diseases such as cancer, heart disease, and diabetes. There is a growing need for targeted treatments that address the specific causes and progression of each patient's condition. In the realm of blockchain in genomics, this demand for personalized medicine drives the need for secure storage and sharing of genomic data. Blockchain technology ensures the protection of individuals' privacy while enabling researchers and healthcare providers to access essential information for personalized treatments. For instance, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines by the Personalized Medicine Coalition (PMC). This underscores the growing significance of personalized medicine in driving the growth of the blockchain in the genomics market.
In May 2024, Rymedi, a U.S.-based provider of blockchain-enabled healthcare data management platforms for diagnostic testing and clinical research, formed a partnership with Precision Genetics. The collaboration aims to enhance healthcare outcomes by integrating Precision Genetics' personalized drug response solution with Rymedi's blockchain clinical trial platform. Their goal is to reduce post-surgical drug risks and optimize recovery. This partnership will help modernize patient care and improve overall healthcare efficiency. Precision Genetics is a U.S.-based provider of genomic testing and precision medicine.
Major companies operating in the blockchain in genomics market report are International Business Machines Corporation, Sharecare Inc., WuXi Nextcode Genomics Inc., Health Utility Network Inc., Chronicled Inc., Medicalchain Ltd., Akiri Inc., Futura Genetics LLC, Nebula Genomics Inc., Medicalchain SA, Digital DNAtix Ltd., EncrypGen Inc., Longenesis, Guardtime AS, ProCredEx LLC, Embleema Inc., Patientory Inc., Shivom Ventures Limited, BurstIQ LLC, Genobank.io Inc., LunaDNA LLC, SimplyVital Health Inc., Zenome.io Ltd., Coral Health Research & Discovery Inc., FarmaTrust Holdings Limited
North America was the largest region in the blockchain in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blockchain in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blockchain in genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The blockchain in genomics market includes revenues earned by entities by providing services such as data sharing and monetization, data security and privacy and data access and management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The blockchain in genomics market also consists of sales of genomic supply chain tracking systems, secure storage systems, internet of things (IoT) devices, and mobile devices. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blockchain In Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on blockchain in genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blockchain in genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blockchain in genomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.